Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ALZHEIMER_DISEASE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | ALZHEIMER_DISEASE |
| Key Genes/Proteins | CYP46A1, EPILEPSY, GFAP |
| Related Diseases | ER_STRESS, INFLAMMATION, INSULIN_RESISTANCE, TYPE2_DIABETES |
| Related Pathways | COMPLEMENT |
graph TD
ALZHEIMER_DISEASE["ALZHEIMER_DISEASE"]
GADD45G["GADD45G"] -->|"activates"| ALZHEIMER_DISEASE
CYP46A1["CYP46A1"] -->|"target for"| ALZHEIMER_DISEASE
INFLAMMATION["INFLAMMATION"] -->|"contributes to"| ALZHEIMER_DISEASE
ER_STRESS["ER_STRESS"] -->|"contributes to"| ALZHEIMER_DISEASE
PHYTOCHEMICALS["PHYTOCHEMICALS"] -->|"treats"| ALZHEIMER_DISEASE
APOE["APOE"] ---|"associated"| ALZHEIMER_DISEASE
COMPLEMENT["COMPLEMENT"] ---|"associated"| ALZHEIMER_DISEASE
TYROBP["TYROBP"] ---|"associated"| ALZHEIMER_DISEASE
C1QC["C1QC"] ---|"associated"| ALZHEIMER_DISEASE
CO9["CO9"] ---|"associated"| ALZHEIMER_DISEASE| Target | Relation | Type | Str |
|---|---|---|---|
| cognitive decline | causes | disease | 0.95 |
| memory loss | causes | unknown | 0.95 |
| neurodegeneration | contributes_to | disease | 0.95 |
| neuroinflammation | associated_with | mechanism | 0.90 |
| neurodegeneration | associated_with | disease | 0.90 |
| oxidative_stress | associated_with | phenotype | 0.85 |
| microglial_activation | associated_with | mechanism | 0.85 |
| protein aggregation | associated_with | mechanism | 0.85 |
| protein_aggregation | involved_in | mechanism | 0.80 |
| neuroinflammation | involved_in | mechanism | 0.70 |
| mitochondrial_dysfunction | associated_with | mechanism | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| tau_propagation | contributes_to | pathway | 0.00 |
| defective_efferocytosis | causes | phenotype | 0.95 |
| neurovascular_dysfunction | associated_with | unknown | 0.95 |
| tau | biomarker_for | unknown | 0.95 |
| amyloid-β | biomarker_for | unknown | 0.95 |
| APOE4 | increases_risk | protein | 0.95 |
| mitochondrial_dysfunction | involved_in | mechanism | 0.95 |
| ageing | increases_risk | unknown | 0.95 |
| mitochondrial_dysfunction | associated_with | mechanism | 0.95 |
| neurodegeneration | contributes_to | disease | 0.95 |
| protein aggregation | associated_with | mechanism | 0.95 |
| TREM1 | contributes_to | unknown | 0.95 |
| TREM2_protein | increases_risk | protein | 0.95 |
| Tau | involved_in | unknown | 0.95 |
| NAD+ depletion | biomarker_for | mechanism | 0.95 |
| HSP70 | modulates | protein | 0.95 |
| TREM2_protein | associated_with | protein | 0.95 |
| microglial_activation | associated_with | mechanism | 0.95 |
| APOE4 | biomarker_for | protein | 0.95 |
| P-tau181 | biomarker_for | unknown | 0.95 |
| TREM2_protein | implicated_in | protein | 0.95 |
| network abnormalities | associated_with | unknown | 0.95 |
| interneuron dysfunction | implicated_in | unknown | 0.95 |
| brain aging | increases_risk | unknown | 0.92 |
| oxidative stress | associated_with | mechanism | 0.90 |
| protein aggregation | involved_in | mechanism | 0.90 |
| HK2 | implicated_in | protein | 0.90 |
| mitochondrial_dysfunction | contributes_to | mechanism | 0.90 |
| microglial_activation | involved_in | mechanism | 0.90 |
| protein misfolding | contributes_to | unknown | 0.90 |
| network hypersynchrony | contributes_to | unknown | 0.90 |
| ferroptosis | contributes_to | mechanism | 0.90 |
| ABCA7 | increases_risk | unknown | 0.90 |
| glymphatic_clearance | involved_in | mechanism | 0.90 |
| necroptosis | implicated_in | unknown | 0.90 |
| cerebral_blood_flow_regulation | implicated_in | unknown | 0.90 |
| glymphatic_clearance | associated_with | mechanism | 0.90 |
| phagocytosis | modulates | mechanism | 0.90 |
| Semagacestat | causes | drug | 0.90 |
| spatial_navigation | risk_factor_for | cognitive_function | 0.90 |
| glymphatic_clearance | contributes_to | mechanism | 0.88 |
| Copper | associated_with | unknown | 0.85 |
| GCase | biomarker_for | protein | 0.85 |
| circadian disruption | associated_with | mechanism | 0.85 |
| metabolic dysregulation | associated_with | unknown | 0.85 |
| oxidative_stress | involved_in | phenotype | 0.85 |
| protein_aggregation | associated_with | mechanism | 0.85 |
| microglial_activation | contributes_to | mechanism | 0.85 |
| neurovascular_coupling | contributes_to | unknown | 0.85 |
| aging | contributes_to | unknown | 0.85 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| APOE4-driven loss of neuronal PI(4,5)P2 bridges ganglioside- | 0.380 | Alzheimer disease | Lipid metabolism dysregulation and membr |
Scientific analyses that reference this entity
memory and navigation | 2026-04-08 | 7 hypotheses Top: 0.455
clinical neurology | 2026-04-08 | 7 hypotheses Top: 0.455
neurodegeneration | 2026-04-04 | 14 hypotheses Top: 0.651
neurodegeneration | 2026-04-04 | 15 hypotheses Top: 0.814
neurodegeneration | 2026-04-03 | 14 hypotheses Top: 0.827
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 4 · Score: 0.50 · 2026-04-27
closed · Rounds: 4 · Score: 0.40 · 2026-04-27
closed · Rounds: 4 · Score: 0.40 · 2026-04-27
closed · Rounds: 4 · Score: 0.90 · 2026-04-12
closed · Rounds: 4 · Score: 0.86 · 2026-04-12
closed · Rounds: 5 · Score: 0.95 · 2026-04-12
closed · Rounds: 5 · Score: 0.93 · 2026-04-11
closed · Rounds: 4 · Score: 0.79 · 2026-04-09
closed · Rounds: 4 · Score: 0.95 · 2026-04-09
Hypotheses and analyses mentioning ALZHEIMER_DISEASE in their description or question text
No additional research found